CooperVision® received approval for its new Biofinity® toric multifocal contact lenses from the U.S. Food and Drug Administration (FDA). The highly-anticipated product combines the proven optical designs of CooperVision’s Biofinity® toric —the most prescribed toric lens on the market1—and Biofinity® multifocal to provide patients with the combined astigmatism and presbyopia vision correction they deserve.